SOD2 in mitochondrial dysfunction and neurodegeneration

Free Radical Biology and Medicine

Volumn 62, Issue , 2013, Pages 4-12

  Flynn, James M ^a   Melovn, Simon ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Aging; Free radicals; Mitochondria; Neurodegeneration; Oxidative stress; Superoxide dismutase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMYLOID BETA PROTEIN; GELATINASE B; HYDROGEN PEROXIDE; IDEBENONE; MANGANESE SUPEROXIDE DISMUTASE; NUCLEIC ACID; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FOXO; UBIDECARENONE;

AGING; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANTIOXIDANT ACTIVITY; BRAIN ISCHEMIA; CELL STRESS; CELL SURVIVAL; COGNITION; COGNITIVE DEFECT; CYTOTOXICITY; DEGENERATIVE DISEASE; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; GENETIC MANIPULATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IN VIVO STUDY; LIPID PEROXIDATION; LONG TERM POTENTIATION; METABOLIC REGULATION; MILD COGNITIVE IMPAIRMENT; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; REPERFUSION INJURY; RESPIRATORY CHAIN; REVIEW; RISK FACTOR;

EUKARYOTA;

EID: 84884908350     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.05.027     Document Type: Review

References (135)

1. Harman, D. The biologic clock: the mitochondria? J. Am. Geriatr. Soc 20: 145-147; 1972.
2. Pérez VI, Bokov A, Remmen HV, Mele J, Ran Q, Ikeno Y, Richardson A. Is the oxidative stress theory of aging dead? Biochim. Biophys. Acta Gen. Subj. 2009, 1790: 1005-1014.
3. Roberts, BR; Ryan, TM; Bush, AI; Masters, CL; Duce, JA. The role of metallo-biology and amyloid-ß peptides in Alzheimer's disease. J. Neurochem 120: 149-166; 2011.
4. James, SA; Volitakis, I; Adlard, PA; Duce, JA; Masters, CL; Cherny, RA; Bush, AI. Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic. Biol. Med 52: 298-302; 2012.
5. Greenough, MA; Camakaris, J; Bush, AI. Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem. Int 62: 540-555; 2013.
6. Bush, AI. The metal theory of Alzheimer's disease. J. Alzheimers Dis 33(Suppl. 1): S277-281; 2013.
7. Andersen, JK. Oxidative stress in neurodegeneration: cause or consequence? Nat. Med 10(Suppl):S18-25; 2004. (Pubitemid 38901863)
8. Marklund, SL. Extracellular superoxide dismutase in human tissues and human cell lines. J. Clin. Invest 74 : 1398-1403; 1984. (Pubitemid 15206836)
9. Strålin, P; Karlsson, K; Johansson, BO; Marklund, SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler. Thromb. Vasc. Biol 15: 2032-2036; 1995.
10. Fukai, T; Siegfried, MR; Ushio-Fukai, M; Cheng, Y; Kojda, G; Harrison, DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J. Clin. Invest 105: 1631-1639; 2000.
11. Fattman, CL; Schaefer, LM; Oury, TD. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35: 236-256; 2003. (Pubitemid 37288924)
12. Fukai, T; Ushio-Fukai, M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid. Redox Signaling 15: 1583-1606; 2011.
13. Chan, PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab 21: 2-14; 20 01.
14. Crapo, JD; Oury, T; Rabouille, C; Slot, JW; Copper, Chang LY. zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc. Natl. Acad. Sci. USA 89: 10405-10409; 1992.
15. Sturtz, LA; Diekert, K; Jensen, LT; Lill, R; Culotta, VC. A fraction of yeast Cu, Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria: a physiological role for SOD1 in guarding against mitochondrial oxidative damage. J. Biol. Chem 276: 38084-38089; 2001.
16. Vijayvergiya, C; Beal, MF; Buck, J; Manfredi, G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J. Neurosci 25: 2463-2470; 2005. (Pubitemid 40365156)
17. Kawamata, H; Manfredi, G. Different regulation of wild-type and mutant Cu, Zn superoxide dismutase localization in mammalian mitochondria. Hum. Mol. Genet 17: 3303-3317; 2008.
18. Okado-Matsumoto, A; Fridovich, I. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J. Biol. Chem 276: 38388-38393; 2001.
19. Barrett, EF; Barrett, JN; David, G. Mitochondria in motor nerve terminals: function in health and in mutant superoxide dismutase 1 mouse models of familial ALS. J. Bioenerg. Biomembr 43: 581-586; 2011.
20. Carrì, MT; Cozzolino, M. SOD1 and mitochondria in ALS: a dangerous liaison. J. Bioenerg. Biomembr. 43: 593-599; 2011.
21. Al-Chalabi, A; Jones, A; Troakes, C; King, A; Al-Sarraj, S; van den Berg, LH. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuro-pathol 124: 339-352; 2012.
22. Weisiger, RA; Fridovich, I. Mitochondrial superoxide dismutase. J. Biol. Chem. 248: 4793-4796; 1973.
23. Murphy, MP. How mitochondria produce reactive oxygen species. Biochem. J. 417: 1; 2009.
24. Fridovich, I. Oxygen toxicity: a radical explanation. J. Exp. Biol. 201: 1203-1209; 1998. (Pubitemid 28278324)
25. Pacifici, RE; Davies, KJ. Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 37: 166-180; 1991.
26. Gupta, A; Hasan, M; Chander, R; Kapoor, NK. Age-related elevation of lipid peroxidation products: diminution of superoxide dismutase activity in the central nervous system of rats. Gerontology 37: 305-309; 1991.
27. Daly, MJ. Death by protein damage in irradiated cells. DNA Repair 11 : 12-21; 2012.
28. Grimm, S; Hoehn, A; Davies, KJ; Grune, T. Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease. Free Radic. Res 45: 73-88; 2011.
29. Grune, T; Davies, KJA. The proteasomal system and HNE-modified proteins. Mol. Aspects Med 24: 195-204; 2003. (Pubitemid 36945019)
30. Dubois, B; Feldman, HH; Jacova, C; Dekosky, ST; Barberger-Gateau, P; Cummings, J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6: 734-746; 2007. (Pubitemid 47058377)
31. McKhann, G; Drachman, D; Folstein, M; Katzman, R; Price, D; Stadlan, EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944; 1984.
32. Reitz, C; Brayne, C; Mayeux, R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 7: 137-152; 2011.
33. Perry, G; Nunomura, A; Hirai, K; Zhu, X; Pérez, M; Avila, J, et al. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic. Biol. Med 33: 1475-1479; 2002. (Pubitemid 35351590)
34. Leuner, K; Schütt, T; Kurz, C; Eckert, SH; Schiller, C; Occhipinti, A, et al. Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid. Redox Signaling 16: 1421-1433; 2012.
35. Butterfield, DA; Lauderback, CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid ß-peptide-associated free radical oxidative stress. Free Radic. Biol. Med 32: 1050-1060; 2002. (Pubitemid 34603342)
36. Sultana, R; Perluigi, M; Butterfield, DA. Protein oxidation and lipid peroxida-tion in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signaling 8: 2021-2037; 2006. (Pubitemid 46499264)
37. Gustaw-Rothenberg, K; Lerner, A; Bonda, DJ; Lee, HG; Zhu, X; Perry, G; Smith, MA. Biomarkers in Alzheimer's disease: past. present and future. Biomarkers Med. 4: 15-26; 2010.
38. Butterfield DA, Bader Lange ML, Sultana R. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2010, 1801: 924-929.
39. De Leo, ME; Borrello, S; Passantino, M; Palazzotti, B; Mordente, A; Daniele, A, et al. Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neurosci. Lett 250: 173 -17 6 ; 1998. (Pubitemid 28355805)
40. Lin, MT; Beal, MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795; 2006. (Pubitemid 44622683)
41. Cha, M-Y; Han, S-H; Son, SM; Hong, H-S; Choi, Y-J; Byun, J; Mook-Jung, I. Mitochondria-specific accumulation of amyloid ß induces mitochondrial dysfunction leading to apoptotic cell death. PLoS One 7:e34929; 2012.
42. Casley, CS; Canevari, L; Land, JM; Clark, JB; Sharpe, MA. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem 80: 91-100; 2002. (Pubitemid 34614581)
43. Coskun P, Wyrembak J, Schriner SE, Chen H-W, Marciniack C, Laferla F, Wallace DC. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim. Biophys. Acta 2012, 1820: 553-564.
44. Wallace, DC.; Mitochondrial, DNA mutations in disease and aging. Environ. Mol. Mutagen. 51: 440-450; 2010.
45. Choi, SW; Gerencser, AA; Ng, R; Flynn, JM; Melov, S; Danielson, SR, et al. No consistent bioenergetic defects in presynaptic nerve terminals isolated from mouse models of Alzheimer's disease. J. Neurosci 32: 16775-16784; 2012.
46. Melov, S; Adlard, PA; Morten, K; Johnson, F; Golden, TR; Hinerfeld, D, et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2:e536; 2007.
47. Li, F; Calingasan, NY; Yu, F; Mauck, WM; Toidze, M; Almeida, CG, et al. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem 89: 1308-1312; 2004. (Pubitemid 38715849)
48. Esposito, L; Raber, J; Kekonius, L; Yan, F; Yu, GQ; Bien-Ly, N, et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci 26: 5167-5179; 2006. (Pubitemid 44315298)
49. Ma, T; Hoeffer, CA; Wong, H; Massaad, CA; Zhou, P; Iadecola, C, et al. Amyloid-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. J. Neurosci 31: 5589-5595; 2011.
50. Dickson, DW. Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harbor Perspect. Med 2:a009258; 2012, http://dx.doi.org/10.1101/ cshperspect.a009258.
51. Elbaz, A; Grigoletto, F; Baldereschi, M; Breteler, MM; Manubens-Bertran, JM; Lopez-Pousa, S, et al. Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. Europarkinson Study Group. Neurology 52: 1876-1882; 1999. (Pubitemid 29260903)
52. Puschmann, A. Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat. Disord 19: 407-415; 2013.
53. Valente, EM; Abou-Sleiman, PM; Caputo, V; Muqit, MMK; Harvey, K; Gispert, S, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 115 8 -1160; 2004. (Pubitemid 38661852)
54. Bonifati, V; Rizzu, P; van Baren, MJ; Schaap, O; Breedveld, GJ; Krieger, E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259; 2003. (Pubitemid 36131051)
55. Shimizu, N; Kitada, T; Asakawa, S; Hattori, N; Matsumine, H; Yamamura, Y, et al. Access: mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392: 605-608; 1998. (Pubitemid 28207717)
56. Strauss, KM; Martins, LM; Plun-Favreau, H; Marx, FP; Kautzmann, S; Berg, D, et al. Loss of function mutations in the gene encoding omi/htra2 in Parkinson's disease. Hum. Mol. Genet 14: 2099-2111 ; 2 0 0 5 . (Pubitemid 41418010)
57. Radunovic, A; Porto, WG; Zeman, S; Leigh, PN. Increased mitochondrial superoxide dismutase activity in Parkinson's disease but not amyotrophic lateral sclerosis motor cortex. Neurosci. Lett 239: 105-108; 1997. (Pubitemid 28060211)
58. Ferrer, I; Perez, E; Dalfo, E; Barrachina, M. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. Neurosci. Lett 415: 205-209; 2007. (Pubitemid 46420396)
59. Ihara, Y; Chuda, M; Kuroda, S; Hayabara, T. Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data. J. Neurol. Sci 170: 90-95; 1999. (Pubitemid 29528530)
60. Marttila, RJ; Lorentz, H; Rinne, UK. Oxygen toxicity protecting enzymes in Parkinson's disease: increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J. Neurol. Sci 86: 321-331; 1988.
61. Surmeier, DJ; Guzman, JN; Sanchez-Padilla, J; Schumacker, PT. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease. Neuroscience 198: 221-231; 2011.
62. Varcin M, Bentea E, Michotte Y, Sarre S. Oxidative stress in genetic mouse models of Parkinson's disease. Oxid. Med. Cell. Longevity 2012, 2012: 624925.
63. Mythri, RB; Venkateshappa, C; Harish, G; Mahadevan, A; Muthane, UB; Yasha, TC, et al. Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains. Neurochem. Res 36: 1452-1463; 2011.
64. Jenner, P. Oxidative stress and Parkinson's disease. In: Vinken, P. J., Bruyn, G. W., editors. Handbook of Clinical Neurology, Vol. 83. Amsterdam: Elsevier; 2007. p. 507-520.
65. Fukuda, T. Neurotoxicity of MPTP. Neuropathology 21: 323-332; 2001. (Pubitemid 34130640)
66. Tipton, KF; Singer, TP. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem 61: 1191-1206; 1993. (Pubitemid 23285075)
67. Choi, SW; Gerencser, AA; Lee, DW; Rajagopalan, S; Nicholls, DG; Andersen, JK; Brand, MD. Intrinsic bioenergetic properties and stress sensitivity of dopaminergic synaptosomes. J. Neurosci 31: 4524-4534; 2011.
68. Exner, N; Lutz, AK; Haass, C; Winklhofer, KF. Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J. 31: 3038-3062; 2012.
69. Fukui, M; Zhu, BT. Mitochondrial superoxide dismutase SOD2, but not cytosolic SOD1, plays a critical role in protection against glutamate-induced oxidative stress and cell death in HT22 neuronal cells. Free Radic. Biol. Med 48: 821-830; 2010.
70. Kaur, D; Andersen, J. Does cellular iron dysregulation play a causative role in Parkinson's disease? Ageing Res Rev 3: 327-343; 2004. (Pubitemid 38844698)
71. Yamaguchi, H; Shen, J. Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice. Mol. Neurodegener 2: 10; 2007.
72. Andres-Mateos, E; Perier, C; Zhang, L; Blanchard-Fillion, B; Greco, TM; Thomas, B, et al. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. USA 104: 14807-14812; 2007. (Pubitemid 350003224)
73. Sun, SY; An, CN; Pu, XP. DJ-1 protein protects dopaminergic neurons against 6-OHDA/mg-132-induced neurotoxicity in rats. Brain Res. Bull 88: 609-616; 2012.
74. Koh, H; Kim, H; Kim, MJ; Park, J; Lee, HJ; Chung, J. Silent information regulator 2 (sir2) and forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila pten-induced kinase 1 (PINK1) null mutant. J. Biol. Chem 287: 12750-12758; 2012.
75. Moskowitz, MA; Lo, EH; Iadecola, C. The science of stroke: mechanisms in search of treatments. Neuron 67: 181-198; 2010.
76. Moro, MA; Almeida, A; Bolaños, JP; Lizasoain, I. Mitochondrial respiratory chain and free radical generation in stroke. Free Radic. Biol. Med 39: 1291-1304; 2005. (Pubitemid 41540085)
77. Kristián, T. Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. Cell Calcium 36: 221-233; 2004. (Pubitemid 38992349)
78. Jaffer, H; Morris, VB; Stewart, D; Labhasetwar, V. Advances in stroke therapy. Drug Delivery Transl. Res 1: 409-419; 2011.
79. Margaill, I; Plotkine, M; Lerouet, D. Antioxidant strategies in the treatment of stroke. Free Radic. Biol. Med. 39: 429-443; 2005. (Pubitemid 41021642)
80. Chen, H; Yoshioka, H; Kim, GS; Jung, JE; Okami, N; Sakata, H, et al. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid. Redox Signaling 14: 1505-1517; 2011.
81. Kelly, PJ; Morrow, JD; Ning, M; Koroshetz, W; Lo, EH; Terry, E, et al. Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study. Stroke 39: 100-104; 2008.
82. Ciancarelli, I; Di Massimo, C; De Amicis, D; Carolei, A; Tozzi Ciancarelli, MG. Evidence of redox unbalance in post-acute ischemic stroke patients. Curr. Neurovasc. Res 9: 85-90; 2012.
83. Gariballa, SE; Hutchin, TP; Sinclair, AJ. Antioxidant capacity after acute ischaemic stroke. QJM 95: 685-690; 2002. (Pubitemid 35203637)
84. Connell, BJ; Saleh, M; Khan, BV; Saleh, TM. Lipoic acid protects against reperfusion injury in the early stages of cerebral ischemia. Brain Res 1375: 128-136; 2011.
85. Jung, JE; Kim, GS; Narasimhan, P; Song, YS; Chan, PH. Regulation of Mn-superoxide dismutase activity and neuroprotection by STAT3 in mice after cerebral ischemia. J. Neurosci 29: 7003-7014; 2009.
86. Buga, A-M; Scholz, CJ; Kumar, S; Herndon, JG; Alexandru, D; Cojocaru, GR, et al. Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke. PLoS One 7: e50985; 2012.
87. Popa-Wagner, A; Carmichael, ST; Kokaia, Z; Kessler, C; Walker, LC. The response of the aged brain to stroke: too much, too soon? Curr. Neurovasc. Res 4: 216-227; 2007. (Pubitemid 47235973)
88. Nilupul Perera, M; Ma, HK; Arakawa, S; Howells, DW; Markus, R; Rowe, CC; Donnan, GA. Inflammation following stroke. J. Clin. Neurosci. 13: 1-8; 2006. (Pubitemid 43061121)
89. Pannese, E. Morphological changes in nerve cells during normal aging. Brain Struct. Funct 216: 85-89; 2011.
90. Ashford JW, Atwood CS, Blass JP, Bowen RL, Finch CE, Iqbal K, et al. What is aging? What is its role in Alzheimer's disease? What can we do about it? J. Alzheimers Dis. 2005, 7: 247-253, discussion 255-262. (Pubitemid 40917255)
91. de Groot, LCPMG; Verheijden, MW; de Henauw, S; Schroll, M; van Staveren, WA SENECA Investigators. Lifestyle, nutritional status, health, and mortality in elderly people across Europe: a review of the longitudinal results of the SENECA study. J. Gerontol. A Biol. Sci. Med. Sci. 59: 1277-1284; 2004. (Pubitemid 40209413)
92. Lores-Arnaiz, S; Bustamante, J. Age-related alterations in mitochondrial physiological parameters and nitric oxide production in synaptic and non-synaptic brain cortex mitochondria. Neuroscience 188: 117 -124; 2011.
93. Flynn, JM; Choi, SW; Day, NU; Gerencser, AA; Hubbard, A; Melov, S. Impaired spare respiratory capacity in cortical synaptosomes from Sod2 null mice. Free Radic. Biol. Med 50: 866-873; 2011.
94. Massaad, CA; Klann, E. Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid. Redox Signaling 14: 2013-2054; 2011.
95. Fukui, K; Onodera, K; Shinkai, T; Suzuki, S; Urano, S. Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems. Ann. N. Y. Acad. Sci 928: 168-175; 2001. (Pubitemid 32386078)
96. Forster, MJ; Dubey, A; Dawson, KM; Stutts, WA; Lal, H; Sohal, RS. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc. Natl. Acad. Sci. USA 93: 4765-4769; 19 96 . (Pubitemid 26162825)
97. Berr, C; Balansard, B; Arnaud, J; Roussel, AM; Alperovitch, A. Cognitive decline is associated with systemic oxidative stress: the EVA Study. Etude du Vieillissement Arteriel. J. Am. Geriatr. Soc 48: 1285-1291; 2000.
98. Perkins, AJ; Hendrie, HC; Callahan, CM; Gao, S; Unverzagt, FW; Xu, Y, et al. Association of antioxidants with memory in a multiethnic elderly sample using the third National Health and Nutrition Examination Survey. Am. J. Epidemiol 150: 37-44; 1999. (Pubitemid 29297266)
99. Polidori, MC; De Spirt, S; Stahl, W; Pientka, L. Conflict of evidence: carotenoids and other micronutrients in the prevention and treatment of cognitive impairment. BioFactors 38: 167-171; 2012.
100. Clausen, A; Doctrow, S; Baudry, M. Prevention of cognitive deficits and brain oxidative stress with superoxide dismutase/catalase mimetics in aged mice. Neurobiol. Aging 31: 425-433; 2010.
101. Etgen, T; Sander, D; Bickel, H; Forstl, H. Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch. Arzteblatt Int 108: 743-750; 2011.
102. Winker, R; Lukas, I; Perkmann, T; Haslacher, H; Ponocny, E; Lehrner, J, et al. Cognitive function in elderly marathon runners: cross-sectional data from the marathon trial (APSOEM). Wien. Klin. Wochenschr 122: 704-716; 2010.
103. Radak, Z; Chung, HY; Koltai, E; Taylor, AW; Goto, S. Exercise, oxidative stress and hormesis. Ageing Res. Rev. 7: 34-42; 2008.
104. Radak, Z; Chung, HY; Goto, S. Exercise and hormesis: oxidative stress-related adaptation for successful aging. Biogerontology 6: 71-75; 2005. (Pubitemid 41583294)
105. Baker, LD; Bayer-Carter, JL; Skinner, J; Montine, TJ; Cholerton, BA; Callaghan, M, et al. High-intensity physical activity modulates diet effects on cere-brospinal amyloid-beta levels in normal aging and mild cognitive impairment. J. Alzheimers Dis 28: 137-146; 2012.
106. Raichle, ME; MacLeod, AM; Snyder, AZ; Powers, WJ; Gusnard, DA; Shulman, GL. A default mode of brain function. Proc. Natl. Acad. Sci. USA 98: 676-682; 2001. (Pubitemid 32105102)
107. Li, Y; Huang, TT; Carlson, EJ; Melov, S; Ursell, PC; Olson, JL, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet 11 : 376-381; 1995.
108. Melov, S; Schneider, JA; Day, BJ; Hinerfeld, D; Coskun, P; Mirra, SS, et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet 18 : 159-163; 1998. (Pubitemid 28082464)
109. Melov, S; Coskun, P; Wallace, D. Mouse models of mitochondrial disease, oxidative stress, and senescence. Mutat. Res. 434: 233-242; 1999. (Pubitemid 29352258)
110. Melov, S; Doctrow, SR; Schneider, JA; Haberson, J; Patel, M; Coskun, PE, et al. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J. Neurosci 21: 8348-8353; 2001. (Pubitemid 33051432)
111. Hinerfeld, D; Traini, MD; Weinberger, RP; Cochran, B; Doctrow, SR; Harry, J; Melov, S. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious anti-oxidant therapy in superoxide dismutase 2 null mice. J. Neurochem 88: 657-667; 2004. (Pubitemid 38140210)
112. Fujimura, M; Morita-Fujimura, Y; Kawase, M; Copin, JC; Calagui, B; Epstein, CJ; Chan, PH. Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J. Neurosci 19: 3414-3422; 1999. (Pubitemid 29203121)
113. Andreassen, OA; Ferrante, RJ; Dedeoglu, A; Albers, DW; Klivenyi, P; Carlson, EJ, et al. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate. 3-nitropropionic acid, and MPTP. Exp. Neurol 167: 189-195; 2001. (Pubitemid 32066422)
114. Huang, TT; Carlson, EJ; Kozy, HM; Mantha, S; Goodman, SI; Ursell, PC; Epstein, CJ. Genetic modification of prenatal lethality and dilated cardiomyo-pathy in Mn superoxide dismutase mutant mice. Free Radic. Biol. Med 31: 110 1 -1110; 2001. (Pubitemid 33000132)
115. Melov, S; Coskun, P; Patel, M; Tuinstra, R; Cottrell, B; Jun, A, et al. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. USA 96: 846-851; 1999. (Pubitemid 29072146)
116. Van Remmen, H; Ikeno, Y; Hamilton, M; Pahlavani, M; Wolf, N; Thorpe, SR, et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics 16: 29-37; 2003. (Pubitemid 38420018)
117. Hu, D; Cao, P; Thiels, E; Chu, CT; Wu, GY; Oury, TD; Klann, E. Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochon-drial superoxide dismutase. Neurobiol. Learn. Mem. 87: 372-384; 2007. (Pubitemid 46137009)
118. Jang, YC; Perez, VI; Song, W; Lustgarten, MS; Salmon, AB; Mele, J, et al. Overexpression of Mn superoxide dismutase does not increase life span in mice. J. Gerontol 64: 1114 -1125; 2009.
119. Bitner, BR; Perez-Torres, CJ; Hu, L; Inoue, T; Pautler, RG. Improvements in a mouse model of Alzheimer's disease through SOD2 overexpression are due to functional and not structural alterations. Magn. Reson. Insights 5: 1-6; 2012.
120. Threadgill, DW; Dlugosz, AA; Hansen, LA; Tennenbaum, T; Lichti, U; Yee, D, et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269: 230-234; 1995.
121. Nicholls, DG. Oxidative stress and energy crises in neuronal dysfunction. Ann. N. Y. Acad. Sci 114 7: 53-60; 2008.
122. Weyer, G; Babej-Dolle, RM; Hadler, D; Hofmann, S; Herrmann, WM. A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease. Neuropsychobiology 36: 73-82; 1997. (Pubitemid 27331264)
123. Gutzmann H, Hadler D. Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multi-centre study. J. Neural Transm. Suppl. 1998, 54: 301-310. (Pubitemid 28539367)
124. Thal, LJ; Grundman, M; Berg, J; Ernstrom, K; Margolin, R; Pfeiffer, E, et al. Idebenone treatment fails to slow cognitive decline in Alzheimer's disease. Neurology 61: 1498-1502; 2003. (Pubitemid 37505568)
125. Praticò, D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy. Ann. N. Y. Acad. Sci 114 7: 70-78; 2008.
126. Sano, M; Ernesto, C; Thomas, RG; Klauber, MR; Schafer, K; Grundman, M, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med. 336: 1216-1222; 1997. (Pubitemid 27183651)
127. Lew, MF. The evidence for disease modification in Parkinson's disease. Int. J. Neurosci 121(Suppl. 2): 18-26; 2011.
128. Snow, BJ; Rolfe, FL; Lockhart, MM; Frampton, CM; O'Sullivan, JD; Fung, V, et al. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant mitoQ as a disease-modifying therapy in Parkinson's disease. Mov. Disord 25: 1670-1674; 2010.
129. Engelhart, MJ; Geerlings, MI; Ruitenberg, A; van Swieten, JC; Hofman, A; Witteman, JC; Breteler, MM. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287: 3223-3229; 2002. (Pubitemid 34686103)
130. Morris, MC; Evans, DA; Bienias, JL; Tangney, CC; Bennett, DA; Aggarwal, N, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287: 3230-3237; 2002. (Pubitemid 34686104)
131. Farina, N; Isaac, MG; Clark, AR; Rusted, J; Tabet, N. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst. Rev : 11; 2012.
132. Blacker, D. Neither vitamin E nor donepezil delays progression from amnestic mild cognitive impairment to Alzheimer's disease in the long term. Evid. Based Ment. Health 9: 20; 2006.
133. Pautler, Bitner BR; Perez-Torres, CJ; Hu, L; Inoue, T Pautler. Improvements in a mouse model of Alzheimer's disease through SOD2 overexpression are due to functional and not structural alterations. Magn. Reson. Insights 29: 1-6; 2012.
134. Misawa, H; Nakata, K; Matsuura, J; Moriwaki, Y; Kawashima, K; Shimizu, T, et al. Conditional knockout of Mn superoxide dismutase in postnatal motor neurons reveals resistance to mitochondrial generated superoxide radicals. Neurobiol. Dis 23: 169-177; 2006. (Pubitemid 43903638)
135. Oh, SS; Sullivan, KA; Wilkinson, JE; Backus, C; Hayes, JM; Sakowski, SA; Feldman, EL. Neurodegeneration and early lethality in superoxide dismutase 2-deficient mice: a comprehensive analysis of the central and peripheral nervous systems. Neuroscience 212: 201-213; 2012.)